Medication info

Esoditi Oral Disintegrating Tablet 40 mg (Esomeprazole Magnesium Trihydrate)

Prescription medicationTabletOral · Intravenous injectionApproval withdrawn
Ingredient · strength
Esomeprazole Magnesium Trihydrate›43.38mg / 1 tablet
Manufacturer / importer
Taejun Pharmaceutical Co., Ltd.
Appearance
Round white tablet with gray speckles
Packaging
28 tablets/box [7 tablets/PTP X 4]
Approval status
Approval withdrawn

MFDS item code 201902349 · Approved 2019.04.16

This product's status changed to Approval withdrawn on 2024.01.09. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment and prevention of acid-related disorders, ulcers and Helicobacter pylori infection, and gastrointestinal disorders associated with anti-inflammatory analgesics
Who uses it
Adults · Children
Adult dosage
Place this medicine on the tongue, allow it to dissolve in saliva, and swallow; do not chew or crush it. Administer 40 mg once daily. Administer for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take it for an additional 4 weeks. 20 mg once daily 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Once symptoms have been relieved, subsequent symptoms should be controlled by administering 20 mg once daily. In adults, 20 mg once daily may be administered as needed. On-demand administration is not recommended to control recurrent symptoms in patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug treatment. Administer this medicine 20 mg concomitantly with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical trials exceeding 4 weeks have not been conducted. 20 mg once daily. The treatment duration is 4∼8 weeks. 20 mg once daily. The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses exceeding 80 mg per day should be divided into 2 doses. Administer 40 mg once daily for 4 weeks after initiation of prevention of rebleeding due to gastric or duodenal ulcers by intravenous injection. Renal impairment: No dose adjustment is necessary. Use with caution because there is limited experience in patients with severe renal failure. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. Older adults: No dose adjustment is necessary.
Children's dosage
Adolescents 12 years of age and older — Treatment of erosive reflux esophagitis: 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should continue treatment for an additional 4 weeks. Adolescents 12 years of age and older — Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Adolescents 12 years of age and older — Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, subsequent episodes may be controlled with 20 mg once daily. Children under 12 years of age: There is no experience with administration of this drug to children under 12 years of age.

Ingredients

Manufacturer
Taejun Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of acid-related disorders, ulcers and Helicobacter pylori infection, and gastrointestinal disorders associated with anti-inflammatory analgesics

  • Gastroesophageal reflux disease
  • erosive reflux esophagitis
  • esophagitis
  • symptoms of gastroesophageal reflux disease without esophagitis
  • Helicobacter pylori-positive duodenal ulcers
  • peptic ulcers
  • upper gastrointestinal symptoms
  • pain
  • discomfort
  • burning sensation
  • gastric ulcers and duodenal ulcers related to non-steroidal anti-inflammatory drug use
  • Zollinger-Ellison syndrome
View approved original text

This medication is effective for the long-term maintenance therapy of gastroesophageal reflux disease, particularly erosive reflux esophagitis, and for the prevention of recurrence. It is also used for the relief of symptoms in gastroesophageal reflux disease without esophagitis. It can be used in combination with antibiotics for the treatment and prevention of recurrence of duodenal ulcers and peptic ulcers due to Helicobacter pylori infection. It is also effective for the relief of gastrointestinal symptoms associated with non-steroidal anti-inflammatory drug use and for the treatment and prevention of gastric ulcers and duodenal ulcers. It is used in the treatment of Zollinger-Ellison syndrome and for the prevention of rebleeding of gastric or duodenal ulcers. This medication helps in the treatment and prevention of various gastrointestinal diseases.

Dosage and Administration

Adult dosage

Place this medicine on the tongue, allow it to dissolve in saliva, and swallow; do not chew or crush it. Administer 40 mg once daily. Administer for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take it for an additional 4 weeks. 20 mg once daily 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Once symptoms have been relieved, subsequent symptoms should be controlled by administering 20 mg once daily. In adults, 20 mg once daily may be administered as needed. On-demand administration is not recommended to control recurrent symptoms in patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug treatment. Administer this medicine 20 mg concomitantly with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical trials exceeding 4 weeks have not been conducted. 20 mg once daily. The treatment duration is 4∼8 weeks. 20 mg once daily. The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses exceeding 80 mg per day should be divided into 2 doses. Administer 40 mg once daily for 4 weeks after initiation of prevention of rebleeding due to gastric or duodenal ulcers by intravenous injection. Renal impairment: No dose adjustment is necessary. Use with caution because there is limited experience in patients with severe renal failure. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. Older adults: No dose adjustment is necessary.

Children's dosage

Adolescents 12 years of age and older — Treatment of erosive reflux esophagitis: 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should continue treatment for an additional 4 weeks. Adolescents 12 years of age and older — Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Adolescents 12 years of age and older — Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, subsequent episodes may be controlled with 20 mg once daily. Children under 12 years of age: There is no experience with administration of this drug to children under 12 years of age.

Precautions

This medication should not be used in patients who are allergic to this drug or any of its components, or who have had hypersensitivity reactions to benzimidazole derivatives. Patients allergic to certain antibiotics such as penicillins and macrolides should also be cautious when using this medication together. During treatment with this medication, it is important not to take certain drugs, such as terfenadine, cisapride, pimodivir, and astemizole. Patients taking atazanavir, nelpinavir, or rilpivirine should avoid using this medication. Women who are nursing should not take this medication. This medication can cause a variety of side effects, including a decrease in blood cell count or allergic reactions, insomnia, headache, abdominal pain, liver dysfunction, skin rashes, and other symptoms. Particularly, long-term use can lead to electrolyte imbalances such as hypomagnesemia, thus regular monitoring is necessary. Long-term use of this medication may increase the risk of gastrointestinal bacterial infections; therefore, if diarrhea persists, it is important to consult with a healthcare professional. Additionally, patients with osteoporosis or those at risk of fractures should be cautious as prolonged high-dose use may increase the risk of fractures. This medication may interact with other drugs, so it is essential to inform your healthcare provider of any other medications currently being taken. In particular, when used in combination with warfarin, digoxin, methotrexate, clopidogrel, etc., blood concentration changes need to be monitored. Safety data regarding the use during pregnancy is limited; therefore, if pregnant, consulting a healthcare provider before taking this medication is crucial. If a breastfeeding woman takes this medication, the safety of the baby has not been established, and nursing should be discontinued or an alternative medication should be chosen. In case of overdose, there are no specific antidotes; treatment should be symptomatic, following the guidance of healthcare professionals. This medication should be kept out of reach of children, and transferring it to other containers may lead to accidental ingestion or quality deterioration.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distention, allergic reaction, back pain, chest pain, sternal pain, facial edema, facial flushing, fatigue, influenza-like illness, generalized edema, leg edema, malaise, pain, stiffness, anemia, hypopigmented anemia, cervical lymphadenopathy, nosebleeds, leukocytosis, thrombocytopenia, hyperbilirubinemia, impaired liver function, elevated ALT, elevated AST, diabetes, hyperuricemia, elevated ALP, thirst, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, loss of appetite, apathy, increased appetite, confusion, worsening of depression, hypertonicity, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorder, tremor, visual field deficit, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal pruritus, erythematous rash, papular rash, otitis media, abnormal olfaction, loss of taste, taste distortion, abnormal urination, albuminuria, cystitis, dysuria, fungal infection, hematuria, urination frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric fundic polyps, hypocalcemia, hypokalemia, rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is advisable to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature. This storage method helps to maintain the medication's efficacy and prevent degradation.

Appearance and packaging

Appearance

Round white tablet with gray speckles

Package unit

28 tablets/box [7 tablets/PTP X 4]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.